Edu Butyrose
  • Responsabile scientifico
  • Articoli
    • BARRIERA EPITELIALE INTESTINALE
    • BUTIRRATO
    • COVID-19
    • GVHD – Graft-versus-Host Disease / Malattia del trapianto contro l’ospite
    • IBS
    • IBD
    • IDROSADENITE SUPPURATIVA
    • LINEE GUIDA
    • MALATTIE METABOLICHE
    • MALATTIA DIVERTICOLARE
    • RADIOTERAPIA
    • RIGENERAZIONE CUTANEA
  • Interviste
  • Eventi
  • Studi in corso
  • Riviste
  • Documenti utili
  • LSC
  • SILA
  • Logout
Seleziona una pagina

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

da admin | Nov 14, 2023 | RACCOLTA BIBLIOGRAFICA

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility Edoardo Savarino, Fabiana Zingone, Brigida Barberio, Giovanni Marasco, Filiz Akyuz, Hale Akpinar, Oana...

The efect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

da admin | Nov 14, 2023 | RACCOLTA BIBLIOGRAFICA

The efect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial Yi-Yuan Sun, Ming Li, Yue-Yue Li, Li-Xiang Li, Wen-Zhe Zhai, Peng Wang, Xiao-Xiao Yang, Xiang Gu,...

Irritable bowel syndrome

da admin | Mag 26, 2021 | IBS

Non hai il permesso di visualizzare questo contenuto.
Post successivi »

Articoli recenti

  • Global guidelines on diverticular disease of the colon: the Fiesole Consensus report
  • Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain
  • Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
  • Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
  • Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners

Commenti recenti

    ideA-Z Project in progress S.r.l. | P.IVA: IT03373190960
    Corso Giacomo Matteotti, 48 – 20081 – Abbiategrasso (MI) | info@idea-z.it